- Home
- ANL vs MURA Comparison
ANL vs MURA Comparison
Compare ANL & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- MURA
- Stock Information
- Founded
- ANL 2004
- MURA 2013
- Country
- ANL Cayman Islands
- MURA Ireland
- Employees
- ANL N/A
- MURA N/A
- Industry
- ANL
- MURA
- Sector
- ANL
- MURA
- Exchange
- ANL Nasdaq
- MURA Nasdaq
- Market Cap
- ANL 81.9M
- MURA N/A
- IPO Year
- ANL 2023
- MURA N/A
- Fundamental
- Price
- ANL $2.05
- MURA $1.26
- Analyst Decision
- ANL Strong Buy
- MURA Strong Buy
- Analyst Count
- ANL 2
- MURA 5
- Target Price
- ANL $9.00
- MURA $13.00
- AVG Volume (30 Days)
- ANL 6.8K
- MURA 421.2K
- Earning Date
- ANL 04-08-2025
- MURA 03-11-2025
- Dividend Yield
- ANL N/A
- MURA N/A
- EPS Growth
- ANL N/A
- MURA N/A
- EPS
- ANL N/A
- MURA N/A
- Revenue
- ANL $5,000,000.00
- MURA N/A
- Revenue This Year
- ANL N/A
- MURA $79.64
- Revenue Next Year
- ANL N/A
- MURA N/A
- P/E Ratio
- ANL N/A
- MURA N/A
- Revenue Growth
- ANL N/A
- MURA N/A
- 52 Week Low
- ANL $1.85
- MURA $1.11
- 52 Week High
- ANL $17.48
- MURA $5.02
- Technical
- Relative Strength Index (RSI)
- ANL 38.59
- MURA 19.14
- Support Level
- ANL $2.02
- MURA $3.77
- Resistance Level
- ANL $2.49
- MURA $4.35
- Average True Range (ATR)
- ANL 0.14
- MURA 0.26
- MACD
- ANL -0.02
- MURA -0.30
- Stochastic Oscillator
- ANL 7.22
- MURA 4.63
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.